SCHEMBL3766110

SCHEMBL3766110

CC1(C)CC(=O)c2sc(N3CCOCC3)c(-c3ccnc(-c4cccc(N5CCC(N)CC5)c4)c3)c2C1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRKCA P17252 2/20 0.42
PRKCQ Q04759 2/20 0.42
KDM1A O60341 1/20 0.36
HDAC1 Q13547 1/20 0.36
JMJD6 Q6NYC1 1/20 0.36
BUB1 O43683 1/20 0.35
MAPK8 P45983 3/20 0.34
MAPK10 P53779 3/20 0.34
MAPK9 P45984 1/20 0.34
PIK3CD O00329 2/20 0.34
PIK3CA P42336 2/20 0.34
PIK3CB P42338 2/20 0.34
PIK3CG P48736 2/20 0.34
CAMK2D Q13557 1/20 0.34
PIM1 P11309 1/20 0.33
JAK2 O60674 1/20 0.33
GABRA1 P14867 1/20 0.33
GABRG2 P18507 1/20 0.33
GABRB3 P28472 1/20 0.33
GABRA5 P31644 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3762331 0.95 PRKCA (0.38) PRKCAPRKCQKDM1AHDAC1JMJD6
SCHEMBL3764999 0.95 PRKCA (0.38) PRKCAPRKCQKDM1AHDAC1JMJD6
SCHEMBL3763086 0.95 PRKCA (0.38) PRKCAPRKCQKDM1AHDAC1JMJD6
SCHEMBL3766682 0.94 KDM1A (0.40) KDM1AHDAC1JMJD6BUB1MAPK8
SCHEMBL3764674 0.93 BUB1 (0.35) PRKCAPRKCQKDM1AHDAC1JMJD6
SCHEMBL16162229 0.91 HRH4 (0.37) PRKCAPRKCQKDM1AHDAC1JMJD6
SCHEMBL3760317 0.89 HTR1A (0.42) KDM1AHDAC1JMJD6BUB1MAPK8
SCHEMBL3765983 0.89 PIK3CA (0.38) PRKCAPRKCQPIK3CDPIK3CAJAK2
SCHEMBL16161748 0.89 PIK3CD (0.37) PRKCAPRKCQKDM1AHDAC1JMJD6
SCHEMBL3754902 0.88 PSMB8 (0.35) BUB1PIK3CDPIK3CAPIK3CBPIK3CG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2029570-B1 FUSED THIOPHENE DERIVATIVES AS KINASE INHIBITORS UCB PHARMA SA (BE) 2014-10-15 EP disclosed
US-8324204-B2 Fused thiophene derivatives as kinase inhibitors UCB PHARMA SA (BE) 2012-12-04 US disclosed
US-20100305066-A1 Fused Thiophene Derivatives as Kinase Inhibitors UCB PHARMA S.A. (BE) 2010-12-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100305066-A1 Fused Thiophene Derivatives as Kinase Inhibitors PIKFYVE, PI4KA, PIK3CA PRKCA 354/4885PRKCQ 341/4885KDM1A 3543/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.